Significant overexpression of IL1R1/INSR and underexpression of CR1 were correlated with CNL-5 risk, which was reported to be associated with AML progression (Stratmann et al., 2022) (Supplementary Figure 9). The gene discussed is IL1R1; the disease is acute myeloid leukemia.